SCHEMBL9045980

SCHEMBL9045980

O=S(=O)(Nc1ncnc(Cl)c1Cc1ccc2ccccc2c1)c1ccc(Cl)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.47
KMT2A Q03164 4/20 0.47
ALDH1A1 P00352 3/20 0.47
HPGD P15428 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
POLB P06746 2/20 0.47
FBP1 P09467 2/20 0.43
EDNRB P24530 1/20 0.42
EDNRA P25101 1/20 0.42
TSHR P16473 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41
BACE1 P56817 1/20 0.41
KDM4E B2RXH2 2/20 0.41
LMNA P02545 2/20 0.41
AR P10275 1/20 0.41
HTT P42858 2/20 0.40
MAPT P10636 1/20 0.40
ESR2 Q92731 1/20 0.40
PTGDR2 Q9Y5Y4 1/20 0.40
CDC25A P30304 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9052960 0.84 EDNRA (0.60) MEN1KMT2AALDH1A1HPGDSMN1; SMN2
SCHEMBL9045459 0.80 ALDH1A1 (0.47) MEN1KMT2AALDH1A1POLBEDNRB
SCHEMBL9496187 0.77 ALDH1A1 (0.63) MEN1KMT2AALDH1A1SMN1; SMN2POLB
SCHEMBL9045082 0.77 SMN1; SMN2 (0.54) KMT2AALDH1A1HPGDSMN1; SMN2BACE1
SCHEMBL9044255 0.76 ALDH1A1 (0.56) MEN1KMT2AALDH1A1HPGDSMN1; SMN2
SCHEMBL9044490 0.75 EDNRA (0.45) MEN1KMT2AALDH1A1POLBEDNRB
SCHEMBL9047760 0.72 EDNRA (0.42) MEN1KMT2AALDH1A1HPGDSMN1; SMN2
SCHEMBL9048076 0.72 KDM4E (0.49) MEN1KMT2AALDH1A1HPGDSMN1; SMN2
SCHEMBL9046333 0.71 MAPT (0.45) MEN1KMT2AALDH1A1HPGDSMN1; SMN2
SCHEMBL9046239 0.71 EDNRA (0.40) MEN1KMT2AALDH1A1HPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0510526-B1 Use of sulfonamides as drug and new sulfonamides HOFFMANN LA ROCHE (CH) 1996-12-04 EP disclosed
US-5270313-A Treatment of circulatory disorders HOFFMANN-LA ROCHE INC. (US) 1993-12-14 US disclosed
EP-0510526-A1 Use of sulfonamides as drug and new sulfonamides F.HOFFMANN-LA ROCHE & CO. AKTIENGESELLSCHAFT (CH) 1992-10-28 EP disclosed